Contact
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Media Coverage
Back to Resources
08/21/2024 | Media Coverage | BioSpace
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
Read More
08/21/2024 | Media Coverage | Precision Medicine Online
PreciseDx Raises $20.7M in Series B Round
Read More
08/02/2024 | Media Coverage | 360Dx
As AI-Based Diagnostics Proliferate, Stakeholders Strive for Regulation Without Stifling Innovation
Read More
07/31/2024 | Media Coverage | Medtech Insight
News We’re Watching: FDA Warning Letters; First Hysterectomy With MIRA Robot; DOJ Finalizes Rule On Accessibility; And More
Read More
05/31/2024 | Media Coverage
COTA, Baptist Health South Florida, PreciseDx collaborate on AI-based test for IBC recurrence
Read More
05/31/2024 | Media Coverage
360Dx Newsletter: Cota, PreciseDx, Baptist Health South Florida to Assess Invasive Breast Cancer Recurrence Test
Read More
05/31/2024 | Media Coverage
Cota, PreciseDx, Baptist Health South Florida to Assess Invasive Breast Cancer Recurrence Test
Read More
05/30/2024 | Media Coverage
COTA, Baptist Health and PreciseDx collaborate on breast cancer test
Read More
05/30/2024 | Media Coverage
Cota, PreciseDx, Baptist Health South Florida to Assess Invasive Breast Cancer Recurrence Test
Read More
05/29/2024 | Media Coverage
New AI Test Aims to Improve Breast Cancer Recurrence Prediction: COTA, PreciseDx, and Baptist Health South Florida Collaborate
Read More
< PREVIOUS
1
2
3
4
…
10
NEXT >
